Teenager's Breakthrough in Cancer Research May Hold Key to Precision Medicine Ashka Shah, a 17 year old high school senior from New York, has made a significant contribution to cancer research with her innovative method of blocking the harmful activity of beta catenin, a key protein linked to liver and colorectal cancers.
This breakthrough has the potential to shift the paradigm in cancer treatment.
The problem with many current cancer treatments is that they often affect both healthy and cancerous cells, leading to debilitating side effects.